APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chinese Medicine Injection for Nervous Diseases

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Chinese Medicine Injection for Nervous Diseases Market Outlook and Growth Opportunities 2026

23 December 2025198 pages

Choose your research edition.

Industry ResearchChinese Medicine Injection for Nervous Diseases Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Chinese Medicine Injection for Nervous Diseases Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Chinese Medicine Injection for Nervous Diseases Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chinese Medicine Injection for Nervous Diseases Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Chinese Medicine Injection for Nervous Diseases Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Chinese Medicine Injection for Nervous Diseases market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Chinese Medicine Injection for Nervous Diseases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chinese Medicine Injection for Nervous Diseases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chinese Medicine Injection for Nervous Diseases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Chinese Medicine Injection for Nervous Diseases market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Chinese Medicine Injection for Nervous Diseases market include ZBD Pharmaceutical, Yunnan Biovalley Pharmaceutical, Wuzhou Pharmaceutical, Tasly Pharmaceuticals, Shenyang Shuangding Pharmaceutical, Mudanjiang Youbo Pharmaceutical, Kunming Longjin Pharmaceutical, Kanion Pharmaceutical and Jinling Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Chinese Medicine Injection for Nervous Diseases market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chinese Medicine Injection for Nervous Diseases and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chinese Medicine Injection for Nervous Diseases sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Chinese Medicine Injection for Nervous Diseases market size, projected growth trends, production technologies, key applications, and end-use industries.

Chinese Medicine Injection for Nervous Diseases Segment by Company

ZBD Pharmaceutical

Yunnan Biovalley Pharmaceutical

Wuzhou Pharmaceutical

Tasly Pharmaceuticals

Shenyang Shuangding Pharmaceutical

Mudanjiang Youbo Pharmaceutical

Kunming Longjin Pharmaceutical

Kanion Pharmaceutical

Jinling Pharmaceutical

Jemincare

Heilongjiang Wusulijiang Pharmaceutical

Chengdu Baiyu Pharmaceutical

Buchang Pharmaceutical

Chinese Medicine Injection for Nervous Diseases Segment by Type

Xueshuantong Injection (Lyophilized)

Xuesetong Injection (Lyophilized)

Ginkgo Biloba Diterpenoids Meglumine Injection

Xingnaojing Injection

Shuxuetong Injection

Danhong Injection

Acanthopanax Senticosus Injection

Other

Chinese Medicine Injection for Nervous Diseases Segment by Application

Secondary Hospital

Tertiary Hospital

Other

Chinese Medicine Injection for Nervous Diseases Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Chinese Medicine Injection for Nervous Diseases status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Chinese Medicine Injection for Nervous Diseases market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Chinese Medicine Injection for Nervous Diseases significant trends, drivers, influence factors in global and regions.

6. To analyze Chinese Medicine Injection for Nervous Diseases competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chinese Medicine Injection for Nervous Diseases market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chinese Medicine Injection for Nervous Diseases and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chinese Medicine Injection for Nervous Diseases.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Chinese Medicine Injection for Nervous Diseases market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Chinese Medicine Injection for Nervous Diseases industry.

Chapter 3: Detailed analysis of Chinese Medicine Injection for Nervous Diseases manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Chinese Medicine Injection for Nervous Diseases in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Chinese Medicine Injection for Nervous Diseases in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Chinese Medicine Injection for Nervous Diseases Industry Trends Table 2. Chinese Medicine Injection for Nervous Diseases Industry Drivers Table 3. Chinese Medicine Injection for Nervous Diseases Industry Opportunities and Challenges Table 4. Chinese Medicine Injection for Nervous Diseases Industry Restraints Table 5. Global Chinese Medicine Injection for Nervous Diseases Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Chinese Medicine Injection for Nervous Diseases Revenue Share by Company (2021-2026) Table 7. Global Chinese Medicine Injection for Nervous Diseases Sales Volume by Company (k units) & (2021-2026) Table 8. Global Chinese Medicine Injection for Nervous Diseases Sales Volume Share by Company (2021-2026) Table 9. Global Chinese Medicine Injection for Nervous Diseases Average Price (USD/unit) of Company (2021-2026) Table 10. Global Chinese Medicine Injection for Nervous Diseases Company Ranking, (2024-2026) & (USD Million) Table 11. Global Chinese Medicine Injection for Nervous Diseases Key Company Manufacturing Base & Headquarters Table 12. Global Chinese Medicine Injection for Nervous Diseases Company, Product Type & Application Table 13. Global Chinese Medicine Injection for Nervous Diseases Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Chinese Medicine Injection for Nervous Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Xueshuantong Injection (Lyophilized) Table 18. Significant Companies of Xuesetong Injection (Lyophilized) Table 19. Significant Companies of Ginkgo Biloba Diterpenoids Meglumine Injection Table 20. Significant Companies of Xingnaojing Injection Table 21. Significant Companies of Shuxuetong Injection Table 22. Significant Companies of Danhong Injection Table 23. Significant Companies of Acanthopanax Senticosus Injection Table 24. Significant Companies of Other Table 25. Global Chinese Medicine Injection for Nervous Diseases Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Chinese Medicine Injection for Nervous Diseases Sales Volume by Type (2021-2026) & (k units) Table 27. Global Chinese Medicine Injection for Nervous Diseases Sales Volume by Type (2027-2032) & (k units) Table 28. Global Chinese Medicine Injection for Nervous Diseases Sales Volume Share by Type (2021-2026) Table 29. Global Chinese Medicine Injection for Nervous Diseases Sales Volume Share by Type (2027-2032) Table 30. Global Chinese Medicine Injection for Nervous Diseases Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Chinese Medicine Injection for Nervous Diseases Sales Value by Type (2021-2026) & (US$ Million) Table 32. Global Chinese Medicine Injection for Nervous Diseases Sales Value by Type (2027-2032) & (US$ Million) Table 33. Global Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type (2021-2026) Table 34. Global Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type (2027-2032) Table 35. Significant Companies of Secondary Hospital Table 36. Significant Companies of Tertiary Hospital Table 37. Significant Companies of Other Table 38. Global Chinese Medicine Injection for Nervous Diseases Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Chinese Medicine Injection for Nervous Diseases Sales Volume by Application (2021-2026) & (k units) Table 40. Global Chinese Medicine Injection for Nervous Diseases Sales Volume by Application (2027-2032) & (k units) Table 41. Global Chinese Medicine Injection for Nervous Diseases Sales Volume Share by Application (2021-2026) Table 42. Global Chinese Medicine Injection for Nervous Diseases Sales Volume Share by Application (2027-2032) Table 43. Global Chinese Medicine Injection for Nervous Diseases Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 44. Global Chinese Medicine Injection for Nervous Diseases Sales Value by Application (2021-2026) & (US$ Million) Table 45. Global Chinese Medicine Injection for Nervous Diseases Sales Value by Application (2027-2032) & (US$ Million) Table 46. Global Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application (2021-2026) Table 47. Global Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application (2027-2032) Table 48. Global Chinese Medicine Injection for Nervous Diseases Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 49. Global Chinese Medicine Injection for Nervous Diseases Sales by Region (2021-2026) & (k units) Table 50. Global Chinese Medicine Injection for Nervous Diseases Sales Market Share by Region (2021-2026) Table 51. Global Chinese Medicine Injection for Nervous Diseases Sales by Region (2027-2032) & (k units) Table 52. Global Chinese Medicine Injection for Nervous Diseases Sales Market Share by Region (2027-2032) Table 53. Global Chinese Medicine Injection for Nervous Diseases Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 54. Global Chinese Medicine Injection for Nervous Diseases Sales Value by Region (2021-2026) & (US$ Million) Table 55. Global Chinese Medicine Injection for Nervous Diseases Sales Value Share by Region (2021-2026) Table 56. Global Chinese Medicine Injection for Nervous Diseases Sales Value by Region (2027-2032) & (US$ Million) Table 57. Global Chinese Medicine Injection for Nervous Diseases Sales Value Share by Region (2027-2032) Table 58. Global Chinese Medicine Injection for Nervous Diseases Market Average Price (USD/unit) by Region (2021-2026) Table 59. Global Chinese Medicine Injection for Nervous Diseases Market Average Price (USD/unit) by Region (2027-2032) Table 60. Global Chinese Medicine Injection for Nervous Diseases Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 61. Global Chinese Medicine Injection for Nervous Diseases Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Chinese Medicine Injection for Nervous Diseases Sales by Country (2021-2026) & (k units) Table 63. Global Chinese Medicine Injection for Nervous Diseases Sales Market Share by Country (2021-2026) Table 64. Global Chinese Medicine Injection for Nervous Diseases Sales by Country (2027-2032) & (k units) Table 65. Global Chinese Medicine Injection for Nervous Diseases Sales Market Share by Country (2027-2032) Table 66. Global Chinese Medicine Injection for Nervous Diseases Sales Value by Country (2021-2026) & (US$ Million) Table 67. Global Chinese Medicine Injection for Nervous Diseases Sales Value Market Share by Country (2021-2026) Table 68. Global Chinese Medicine Injection for Nervous Diseases Sales Value by Country (2027-2032) & (US$ Million) Table 69. Global Chinese Medicine Injection for Nervous Diseases Sales Value Market Share by Country (2027-2032) Table 70. ZBD Pharmaceutical Company Information Table 71. ZBD Pharmaceutical Business Overview Table 72. ZBD Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. ZBD Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio Table 74. ZBD Pharmaceutical Recent Development Table 75. Yunnan Biovalley Pharmaceutical Company Information Table 76. Yunnan Biovalley Pharmaceutical Business Overview Table 77. Yunnan Biovalley Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. Yunnan Biovalley Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio Table 79. Yunnan Biovalley Pharmaceutical Recent Development Table 80. Wuzhou Pharmaceutical Company Information Table 81. Wuzhou Pharmaceutical Business Overview Table 82. Wuzhou Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Wuzhou Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio Table 84. Wuzhou Pharmaceutical Recent Development Table 85. Tasly Pharmaceuticals Company Information Table 86. Tasly Pharmaceuticals Business Overview Table 87. Tasly Pharmaceuticals Chinese Medicine Injection for Nervous Diseases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Tasly Pharmaceuticals Chinese Medicine Injection for Nervous Diseases Product Portfolio Table 89. Tasly Pharmaceuticals Recent Development Table 90. Shenyang Shuangding Pharmaceutical Company Information Table 91. Shenyang Shuangding Pharmaceutical Business Overview Table 92. Shenyang Shuangding Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Shenyang Shuangding Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio Table 94. Shenyang Shuangding Pharmaceutical Recent Development Table 95. Mudanjiang Youbo Pharmaceutical Company Information Table 96. Mudanjiang Youbo Pharmaceutical Business Overview Table 97. Mudanjiang Youbo Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Mudanjiang Youbo Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio Table 99. Mudanjiang Youbo Pharmaceutical Recent Development Table 100. Kunming Longjin Pharmaceutical Company Information Table 101. Kunming Longjin Pharmaceutical Business Overview Table 102. Kunming Longjin Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Kunming Longjin Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio Table 104. Kunming Longjin Pharmaceutical Recent Development Table 105. Kanion Pharmaceutical Company Information Table 106. Kanion Pharmaceutical Business Overview Table 107. Kanion Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Kanion Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio Table 109. Kanion Pharmaceutical Recent Development Table 110. Jinling Pharmaceutical Company Information Table 111. Jinling Pharmaceutical Business Overview Table 112. Jinling Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Jinling Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio Table 114. Jinling Pharmaceutical Recent Development Table 115. Jemincare Company Information Table 116. Jemincare Business Overview Table 117. Jemincare Chinese Medicine Injection for Nervous Diseases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Jemincare Chinese Medicine Injection for Nervous Diseases Product Portfolio Table 119. Jemincare Recent Development Table 120. Heilongjiang Wusulijiang Pharmaceutical Company Information Table 121. Heilongjiang Wusulijiang Pharmaceutical Business Overview Table 122. Heilongjiang Wusulijiang Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Heilongjiang Wusulijiang Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio Table 124. Heilongjiang Wusulijiang Pharmaceutical Recent Development Table 125. Chengdu Baiyu Pharmaceutical Company Information Table 126. Chengdu Baiyu Pharmaceutical Business Overview Table 127. Chengdu Baiyu Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Chengdu Baiyu Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio Table 129. Chengdu Baiyu Pharmaceutical Recent Development Table 130. Buchang Pharmaceutical Company Information Table 131. Buchang Pharmaceutical Business Overview Table 132. Buchang Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Buchang Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio Table 134. Buchang Pharmaceutical Recent Development Table 135. Key Raw Materials Table 136. Raw Materials Key Suppliers Table 137. Chinese Medicine Injection for Nervous Diseases Distributors List Table 138. Chinese Medicine Injection for Nervous Diseases Customers List Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Chinese Medicine Injection for Nervous Diseases Product Image Figure 2. Global Chinese Medicine Injection for Nervous Diseases Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chinese Medicine Injection for Nervous Diseases Sales Value (2021-2032) & (US$ Million) Figure 4. Global Chinese Medicine Injection for Nervous Diseases Sales (2021-2032) & (k units) Figure 5. Global Chinese Medicine Injection for Nervous Diseases Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Chinese Medicine Injection for Nervous Diseases Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Xueshuantong Injection (Lyophilized) Image Figure 10. Xuesetong Injection (Lyophilized) Image Figure 11. Ginkgo Biloba Diterpenoids Meglumine Injection Image Figure 12. Xingnaojing Injection Image Figure 13. Shuxuetong Injection Image Figure 14. Danhong Injection Image Figure 15. Acanthopanax Senticosus Injection Image Figure 16. Other Image Figure 17. Global Chinese Medicine Injection for Nervous Diseases Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 18. Global Chinese Medicine Injection for Nervous Diseases Sales Volume Share 2021 VS 2025 VS 2032 Figure 19. Global Chinese Medicine Injection for Nervous Diseases Sales Volume Share by Type (2021-2032) Figure 20. Global Chinese Medicine Injection for Nervous Diseases Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Chinese Medicine Injection for Nervous Diseases Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type (2021-2032) Figure 23. Secondary Hospital Image Figure 24. Tertiary Hospital Image Figure 25. Other Image Figure 26. Global Chinese Medicine Injection for Nervous Diseases Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Chinese Medicine Injection for Nervous Diseases Sales Volume Share 2021 VS 2025 VS 2032 Figure 28. Global Chinese Medicine Injection for Nervous Diseases Sales Volume Share by Application (2021-2032) Figure 29. Global Chinese Medicine Injection for Nervous Diseases Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Chinese Medicine Injection for Nervous Diseases Sales Value Share 2021 VS 2025 VS 2032 Figure 31. Global Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application (2021-2032) Figure 32. Global Chinese Medicine Injection for Nervous Diseases Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 33. Global Chinese Medicine Injection for Nervous Diseases Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 34. Global Chinese Medicine Injection for Nervous Diseases Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 35. Global Chinese Medicine Injection for Nervous Diseases Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 36. North America Chinese Medicine Injection for Nervous Diseases Sales Value (2021-2032) & (US$ Million) Figure 37. North America Chinese Medicine Injection for Nervous Diseases Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Europe Chinese Medicine Injection for Nervous Diseases Sales Value (2021-2032) & (US$ Million) Figure 39. Europe Chinese Medicine Injection for Nervous Diseases Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Asia-Pacific Chinese Medicine Injection for Nervous Diseases Sales Value (2021-2032) & (US$ Million) Figure 41. Asia-Pacific Chinese Medicine Injection for Nervous Diseases Sales Value Share by Country (%), 2025 VS 2032 Figure 42. South America Chinese Medicine Injection for Nervous Diseases Sales Value (2021-2032) & (US$ Million) Figure 43. South America Chinese Medicine Injection for Nervous Diseases Sales Value Share by Country (%), 2025 VS 2032 Figure 44. Middle East & Africa Chinese Medicine Injection for Nervous Diseases Sales Value (2021-2032) & (US$ Million) Figure 45. Middle East & Africa Chinese Medicine Injection for Nervous Diseases Sales Value Share by Country (%), 2025 VS 2032 Figure 46. USA Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. USA Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. USA Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Canada Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Canada Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Canada Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Mexico Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Mexico Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Mexico Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Germany Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Germany Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Germany Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. France Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. France Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. France Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. U.K. Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. U.K. Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. U.K. Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Italy Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Italy Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Italy Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Spain Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Spain Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Spain Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Russia Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Russia Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Russia Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Netherlands Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Netherlands Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Netherlands Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Nordic Countries Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Nordic Countries Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Nordic Countries Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. China Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. China Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. China Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Japan Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Japan Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Japan Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. South Korea Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. South Korea Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. South Korea Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. India Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. India Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. India Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Australia Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Australia Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Australia Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Southeast Asia Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Southeast Asia Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Southeast Asia Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Brazil Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Brazil Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Brazil Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Argentina Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Argentina Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Argentina Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Chile Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Chile Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Chile Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Colombia Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Colombia Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Colombia Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Peru Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Peru Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Peru Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Saudi Arabia Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Saudi Arabia Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Israel Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Israel Arabia Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Israel Arabia Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. UAE Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. UAE Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. UAE Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Turkey Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Turkey Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Turkey Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Iran Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Iran Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Iran Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Egypt Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 128. Egypt Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 129. Egypt Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 130. Chinese Medicine Injection for Nervous Diseases Value Chain Figure 131. Manufacturing Cost Structure Figure 132. Chinese Medicine Injection for Nervous Diseases Sales Mode & Process Figure 133. Direct Comparison with Distribution Share Figure 134. Distributors Profiles Figure 135. Years Considered Figure 136. Research Process Figure 137. Key Executives Interviewed

Scope & coverage.

Types
  • Xueshuantong Injection (Lyophilized)
  • Xuesetong Injection (Lyophilized)
  • Ginkgo Biloba Diterpenoids Meglumine Injection
  • Xingnaojing Injection
  • Shuxuetong Injection
  • Danhong Injection
  • Acanthopanax Senticosus Injection
  • Other
Applications
  • Secondary Hospital
  • Tertiary Hospital
  • Other
Companies covered
  • ZBD Pharmaceutical
  • Yunnan Biovalley Pharmaceutical
  • Wuzhou Pharmaceutical
  • Tasly Pharmaceuticals
  • Shenyang Shuangding Pharmaceutical
  • Mudanjiang Youbo Pharmaceutical
  • Kunming Longjin Pharmaceutical
  • Kanion Pharmaceutical
  • Jinling Pharmaceutical
  • Jemincare
  • Heilongjiang Wusulijiang Pharmaceutical
  • Chengdu Baiyu Pharmaceutical
  • Buchang Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Chinese Medicine Injection for Nervous Diseases Sales Value (2021-2032)
  4. 1.2.2 Global Chinese Medicine Injection for Nervous Diseases Sales Volume (2021-2032)
  5. 1.2.3 Global Chinese Medicine Injection for Nervous Diseases Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Chinese Medicine Injection for Nervous Diseases Market Dynamics
  1. 2.1 Chinese Medicine Injection for Nervous Diseases Industry Trends
  2. 2.2 Chinese Medicine Injection for Nervous Diseases Industry Drivers
  3. 2.3 Chinese Medicine Injection for Nervous Diseases Industry Opportunities and Challenges
  4. 2.4 Chinese Medicine Injection for Nervous Diseases Industry Restraints
3 Chinese Medicine Injection for Nervous Diseases Market by Company
  1. 3.1 Global Chinese Medicine Injection for Nervous Diseases Company Revenue Ranking in 2025
  2. 3.2 Global Chinese Medicine Injection for Nervous Diseases Revenue by Company (2021-2026)
  3. 3.3 Global Chinese Medicine Injection for Nervous Diseases Sales Volume by Company (2021-2026)
  4. 3.4 Global Chinese Medicine Injection for Nervous Diseases Average Price by Company (2021-2026)
  5. 3.5 Global Chinese Medicine Injection for Nervous Diseases Company Ranking (2024-2026)
  6. 3.6 Global Chinese Medicine Injection for Nervous Diseases Company Manufacturing Base and Headquarters
  7. 3.7 Global Chinese Medicine Injection for Nervous Diseases Company Product Type and Application
  8. 3.8 Global Chinese Medicine Injection for Nervous Diseases Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Chinese Medicine Injection for Nervous Diseases Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Chinese Medicine Injection for Nervous Diseases Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Chinese Medicine Injection for Nervous Diseases Market by Type
  1. 4.1 Chinese Medicine Injection for Nervous Diseases Type Introduction
  2. 4.1.1 Xueshuantong Injection (Lyophilized)
  3. 4.1.2 Xuesetong Injection (Lyophilized)
  4. 4.1.3 Ginkgo Biloba Diterpenoids Meglumine Injection
  5. 4.1.4 Xingnaojing Injection
  6. 4.1.5 Shuxuetong Injection
  7. 4.1.6 Danhong Injection
  8. 4.1.7 Acanthopanax Senticosus Injection
  9. 4.1.8 Other
  10. 4.2 Global Chinese Medicine Injection for Nervous Diseases Sales Volume by Type
  11. 4.2.1 Global Chinese Medicine Injection for Nervous Diseases Sales Volume by Type (2021 VS 2025 VS 2032)
  12. 4.2.2 Global Chinese Medicine Injection for Nervous Diseases Sales Volume by Type (2021-2032)
  13. 4.2.3 Global Chinese Medicine Injection for Nervous Diseases Sales Volume Share by Type (2021-2032)
  14. 4.3 Global Chinese Medicine Injection for Nervous Diseases Sales Value by Type
  15. 4.3.1 Global Chinese Medicine Injection for Nervous Diseases Sales Value by Type (2021 VS 2025 VS 2032)
  16. 4.3.2 Global Chinese Medicine Injection for Nervous Diseases Sales Value by Type (2021-2032)
  17. 4.3.3 Global Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type (2021-2032)
5 Chinese Medicine Injection for Nervous Diseases Market by Application
  1. 5.1 Chinese Medicine Injection for Nervous Diseases Application Introduction
  2. 5.1.1 Secondary Hospital
  3. 5.1.2 Tertiary Hospital
  4. 5.1.3 Other
  5. 5.2 Global Chinese Medicine Injection for Nervous Diseases Sales Volume by Application
  6. 5.2.1 Global Chinese Medicine Injection for Nervous Diseases Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Chinese Medicine Injection for Nervous Diseases Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Chinese Medicine Injection for Nervous Diseases Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Chinese Medicine Injection for Nervous Diseases Sales Value by Application
  10. 5.3.1 Global Chinese Medicine Injection for Nervous Diseases Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Chinese Medicine Injection for Nervous Diseases Sales Value by Application (2021-2032)
  12. 5.3.3 Global Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application (2021-2032)
6 Chinese Medicine Injection for Nervous Diseases Regional Sales and Value Analysis
  1. 6.1 Global Chinese Medicine Injection for Nervous Diseases Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chinese Medicine Injection for Nervous Diseases Sales by Region (2021-2032)
  3. 6.2.1 Global Chinese Medicine Injection for Nervous Diseases Sales by Region: 2021-2026
  4. 6.2.2 Global Chinese Medicine Injection for Nervous Diseases Sales by Region (2027-2032)
  5. 6.3 Global Chinese Medicine Injection for Nervous Diseases Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Chinese Medicine Injection for Nervous Diseases Sales Value by Region (2021-2032)
  7. 6.4.1 Global Chinese Medicine Injection for Nervous Diseases Sales Value by Region: 2021-2026
  8. 6.4.2 Global Chinese Medicine Injection for Nervous Diseases Sales Value by Region (2027-2032)
  9. 6.5 Global Chinese Medicine Injection for Nervous Diseases Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Chinese Medicine Injection for Nervous Diseases Sales Value (2021-2032)
  12. 6.6.2 North America Chinese Medicine Injection for Nervous Diseases Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Chinese Medicine Injection for Nervous Diseases Sales Value (2021-2032)
  15. 6.7.2 Europe Chinese Medicine Injection for Nervous Diseases Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Chinese Medicine Injection for Nervous Diseases Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Chinese Medicine Injection for Nervous Diseases Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Chinese Medicine Injection for Nervous Diseases Sales Value (2021-2032)
  21. 6.9.2 South America Chinese Medicine Injection for Nervous Diseases Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Chinese Medicine Injection for Nervous Diseases Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Chinese Medicine Injection for Nervous Diseases Sales Value Share by Country, 2025 VS 2032
7 Chinese Medicine Injection for Nervous Diseases Country-level Sales and Value Analysis
  1. 7.1 Global Chinese Medicine Injection for Nervous Diseases Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Chinese Medicine Injection for Nervous Diseases Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Chinese Medicine Injection for Nervous Diseases Sales by Country (2021-2032)
  4. 7.3.1 Global Chinese Medicine Injection for Nervous Diseases Sales by Country (2021-2026)
  5. 7.3.2 Global Chinese Medicine Injection for Nervous Diseases Sales by Country (2027-2032)
  6. 7.4 Global Chinese Medicine Injection for Nervous Diseases Sales Value by Country (2021-2032)
  7. 7.4.1 Global Chinese Medicine Injection for Nervous Diseases Sales Value by Country (2021-2026)
  8. 7.4.2 Global Chinese Medicine Injection for Nervous Diseases Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Chinese Medicine Injection for Nervous Diseases Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Chinese Medicine Injection for Nervous Diseases Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Chinese Medicine Injection for Nervous Diseases Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ZBD Pharmaceutical
  2. 8.1.1 ZBD Pharmaceutical Company Information
  3. 8.1.2 ZBD Pharmaceutical Business Overview
  4. 8.1.3 ZBD Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 ZBD Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
  6. 8.1.5 ZBD Pharmaceutical Recent Developments
  7. 8.2 Yunnan Biovalley Pharmaceutical
  8. 8.2.1 Yunnan Biovalley Pharmaceutical Company Information
  9. 8.2.2 Yunnan Biovalley Pharmaceutical Business Overview
  10. 8.2.3 Yunnan Biovalley Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Yunnan Biovalley Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
  12. 8.2.5 Yunnan Biovalley Pharmaceutical Recent Developments
  13. 8.3 Wuzhou Pharmaceutical
  14. 8.3.1 Wuzhou Pharmaceutical Company Information
  15. 8.3.2 Wuzhou Pharmaceutical Business Overview
  16. 8.3.3 Wuzhou Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Wuzhou Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
  18. 8.3.5 Wuzhou Pharmaceutical Recent Developments
  19. 8.4 Tasly Pharmaceuticals
  20. 8.4.1 Tasly Pharmaceuticals Company Information
  21. 8.4.2 Tasly Pharmaceuticals Business Overview
  22. 8.4.3 Tasly Pharmaceuticals Chinese Medicine Injection for Nervous Diseases Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Tasly Pharmaceuticals Chinese Medicine Injection for Nervous Diseases Product Portfolio
  24. 8.4.5 Tasly Pharmaceuticals Recent Developments
  25. 8.5 Shenyang Shuangding Pharmaceutical
  26. 8.5.1 Shenyang Shuangding Pharmaceutical Company Information
  27. 8.5.2 Shenyang Shuangding Pharmaceutical Business Overview
  28. 8.5.3 Shenyang Shuangding Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Shenyang Shuangding Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
  30. 8.5.5 Shenyang Shuangding Pharmaceutical Recent Developments
  31. 8.6 Mudanjiang Youbo Pharmaceutical
  32. 8.6.1 Mudanjiang Youbo Pharmaceutical Company Information
  33. 8.6.2 Mudanjiang Youbo Pharmaceutical Business Overview
  34. 8.6.3 Mudanjiang Youbo Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Mudanjiang Youbo Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
  36. 8.6.5 Mudanjiang Youbo Pharmaceutical Recent Developments
  37. 8.7 Kunming Longjin Pharmaceutical
  38. 8.7.1 Kunming Longjin Pharmaceutical Company Information
  39. 8.7.2 Kunming Longjin Pharmaceutical Business Overview
  40. 8.7.3 Kunming Longjin Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Kunming Longjin Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
  42. 8.7.5 Kunming Longjin Pharmaceutical Recent Developments
  43. 8.8 Kanion Pharmaceutical
  44. 8.8.1 Kanion Pharmaceutical Company Information
  45. 8.8.2 Kanion Pharmaceutical Business Overview
  46. 8.8.3 Kanion Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Kanion Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
  48. 8.8.5 Kanion Pharmaceutical Recent Developments
  49. 8.9 Jinling Pharmaceutical
  50. 8.9.1 Jinling Pharmaceutical Company Information
  51. 8.9.2 Jinling Pharmaceutical Business Overview
  52. 8.9.3 Jinling Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Jinling Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
  54. 8.9.5 Jinling Pharmaceutical Recent Developments
  55. 8.10 Jemincare
  56. 8.10.1 Jemincare Company Information
  57. 8.10.2 Jemincare Business Overview
  58. 8.10.3 Jemincare Chinese Medicine Injection for Nervous Diseases Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Jemincare Chinese Medicine Injection for Nervous Diseases Product Portfolio
  60. 8.10.5 Jemincare Recent Developments
  61. 8.11 Heilongjiang Wusulijiang Pharmaceutical
  62. 8.11.1 Heilongjiang Wusulijiang Pharmaceutical Company Information
  63. 8.11.2 Heilongjiang Wusulijiang Pharmaceutical Business Overview
  64. 8.11.3 Heilongjiang Wusulijiang Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Heilongjiang Wusulijiang Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
  66. 8.11.5 Heilongjiang Wusulijiang Pharmaceutical Recent Developments
  67. 8.12 Chengdu Baiyu Pharmaceutical
  68. 8.12.1 Chengdu Baiyu Pharmaceutical Company Information
  69. 8.12.2 Chengdu Baiyu Pharmaceutical Business Overview
  70. 8.12.3 Chengdu Baiyu Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Chengdu Baiyu Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
  72. 8.12.5 Chengdu Baiyu Pharmaceutical Recent Developments
  73. 8.13 Buchang Pharmaceutical
  74. 8.13.1 Buchang Pharmaceutical Company Information
  75. 8.13.2 Buchang Pharmaceutical Business Overview
  76. 8.13.3 Buchang Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Buchang Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
  78. 8.13.5 Buchang Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Chinese Medicine Injection for Nervous Diseases Value Chain Analysis
  2. 9.1.1 Chinese Medicine Injection for Nervous Diseases Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Chinese Medicine Injection for Nervous Diseases Sales Mode & Process
  6. 9.2 Chinese Medicine Injection for Nervous Diseases Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Chinese Medicine Injection for Nervous Diseases Distributors
  9. 9.2.3 Chinese Medicine Injection for Nervous Diseases Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst